rs1042173
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001045.6(SLC6A4):c.*463T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.415 in 158,042 control chromosomes in the GnomAD database, including 15,111 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.41 ( 14459 hom., cov: 32)
Exomes 𝑓: 0.46 ( 652 hom. )
Consequence
SLC6A4
NM_001045.6 3_prime_UTR
NM_001045.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.803
Genes affected
SLC6A4 (HGNC:11050): (solute carrier family 6 member 4) This gene encodes an integral membrane protein that transports the neurotransmitter serotonin from synaptic spaces into presynaptic neurons. The encoded protein terminates the action of serotonin and recycles it in a sodium-dependent manner. This protein is a target of psychomotor stimulants, such as amphetamines and cocaine, and is a member of the sodium:neurotransmitter symporter family. A repeat length polymorphism in the promoter of this gene has been shown to affect the rate of serotonin uptake. There have been conflicting results in the literature about the possible effect, if any, that this polymorphism may play in behavior and depression. [provided by RefSeq, May 2019]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 17-30197993-A-C is Benign according to our data. Variant chr17-30197993-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 322521.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.796 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC6A4 | NM_001045.6 | c.*463T>G | 3_prime_UTR_variant | 15/15 | ENST00000650711.1 | NP_001036.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC6A4 | ENST00000650711.1 | c.*463T>G | 3_prime_UTR_variant | 15/15 | NM_001045.6 | ENSP00000498537 | P1 | |||
SLC6A4 | ENST00000261707.7 | c.*463T>G | 3_prime_UTR_variant | 15/15 | 1 | ENSP00000261707 | P1 | |||
SLC6A4 | ENST00000579221.5 | c.*780T>G | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 1 | ENSP00000463172 | ||||
SLC6A4 | ENST00000401766.6 | c.*463T>G | 3_prime_UTR_variant | 14/14 | 5 | ENSP00000385822 | P1 |
Frequencies
GnomAD3 genomes AF: 0.413 AC: 62830AN: 151952Hom.: 14461 Cov.: 32
GnomAD3 genomes
AF:
AC:
62830
AN:
151952
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.458 AC: 2736AN: 5970Hom.: 652 Cov.: 0 AF XY: 0.448 AC XY: 1404AN XY: 3134
GnomAD4 exome
AF:
AC:
2736
AN:
5970
Hom.:
Cov.:
0
AF XY:
AC XY:
1404
AN XY:
3134
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.413 AC: 62831AN: 152072Hom.: 14459 Cov.: 32 AF XY: 0.422 AC XY: 31348AN XY: 74348
GnomAD4 genome
AF:
AC:
62831
AN:
152072
Hom.:
Cov.:
32
AF XY:
AC XY:
31348
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2025
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Behavior disorder Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at